Jackson Acquisition Company II (JACS)
| Market Cap | 306.11M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 1.14M |
| Shares Out | 29.59M |
| EPS (ttm) | n/a |
| PE Ratio | 267.75 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 14 |
| Open | 10.33 |
| Previous Close | n/a |
| Day's Range | 10.33 - 10.35 |
| 52-Week Range | 9.94 - 10.41 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About JACS
Jackson Acquisition Company II does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses. It intends to focus its search for a target business in the healthcare services and healthcare technology sector. Jackson Acquisition Company II was incorporated in 2024 and is based in Alpharetta, Georgia. [Read more]
News
Jackson Acquisition Company II Announces Pricing of $200 Million Initial Public Offering
Jackson Acquisition Company II announced today that it priced its initial public offering of 20,000,000 units at $10.00 per unit.
Healthcare-focused SPAC Jackson Acquisition II files for a $200 million IPO
Jackson Acquisition II, a blank check company targeting healthcare, filed on Friday with the SEC to raise up to $200 million in an initial public offering.
Jackson Acquisition Company II IPO Registration Document (S-1)
Jackson Acquisition Company II has filed to go public with an IPO on the New York Stock Exchange (NYSE).